You are here » Home » Companies » Company Overview » Auro Laboratories Ltd

Auro Laboratories Ltd.

BSE: 530233 Sector: Health care
NSE: N.A. ISIN Code: INE292C01011
BSE 00:00 | 27 May 91.65 0.50
(0.55%)
OPEN

91.50

HIGH

93.65

LOW

89.30

NSE 05:30 | 01 Jan Auro Laboratories Ltd
OPEN 91.50
PREVIOUS CLOSE 91.15
VOLUME 1018
52-Week high 195.00
52-Week low 87.00
P/E 14.62
Mkt Cap.(Rs cr) 57
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 91.50
CLOSE 91.15
VOLUME 1018
52-Week high 195.00
52-Week low 87.00
P/E 14.62
Mkt Cap.(Rs cr) 57
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Auro Laboratories Ltd. (AUROLABS) - Company History

Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (API's) Intermediates and Generic Formulations. Auro Laboratories was founded and incorporated in 1992 at Mumbai with a manufacturing facility located at Tarapur 120 Km from Mumbai. Since inception the company has focused on providing quality pharmaceuticals while maintaining high manufacturing standards.The company's primary focus has been on Anti-Diabetic Drugs which is estimated to be one of the fastest growing therapeutic segments. Currently it manufacture Metformin Hydrochloride and Glibenclamide and are on the anvil of introducing others within this segment. Additionally it also undertake Toll/Custom Manufacturing for API's and Intermediates on contract basis. The manufacturing facility operates are per cGMP norms and has an installed capacity in excess of 500 Tonnes per annum.Auro laboratories has made its presence felt in international markets with a bulk of it production being exported to South East Asia Middle East and several European Countries. Some of the countries the company exports to are Egypt Germany Malaysia Singapore South Africa Brazil Spain and United Kingdom.The company has received ISO 9001:2000 and WHO - cGMP certifications. It has also received CERTIFICATE OF SUITABILITY (COS) from the European Directorate of Quality Medicine (EDQM) in September 2006.

.